|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001779,
umls-concept:C0019158,
umls-concept:C0030705,
umls-concept:C0035525,
umls-concept:C0087111,
umls-concept:C0205191,
umls-concept:C0220847,
umls-concept:C0332257,
umls-concept:C0599755,
umls-concept:C0681850,
umls-concept:C0871261,
umls-concept:C0982327,
umls-concept:C1280500,
umls-concept:C1550501,
umls-concept:C1704632,
umls-concept:C1706203,
umls-concept:C1706817,
umls-concept:C2003941,
umls-concept:C2349001,
umls-concept:C2697811,
umls-concept:C2911692
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2007-6-26
|
|
pubmed:abstractText |
In many industrialized countries HCV infection is characterized by an increasing prevalence during ageing; however, data on the efficacy of treatment among older patients are scarce. This study was set up to evaluate the effect of age on the treatment of chronic HCV hepatitis with peginterferon alpha plus ribavirin.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Antiviral Agents,
http://linkedlifedata.com/resource/pubmed/chemical/Drug Carriers,
http://linkedlifedata.com/resource/pubmed/chemical/Hepatitis C Antibodies,
http://linkedlifedata.com/resource/pubmed/chemical/Interferon-alpha,
http://linkedlifedata.com/resource/pubmed/chemical/Polyethylene Glycols,
http://linkedlifedata.com/resource/pubmed/chemical/RNA, Viral,
http://linkedlifedata.com/resource/pubmed/chemical/Recombinant Proteins,
http://linkedlifedata.com/resource/pubmed/chemical/Ribavirin,
http://linkedlifedata.com/resource/pubmed/chemical/interferon alfa-2a,
http://linkedlifedata.com/resource/pubmed/chemical/peginterferon alfa-2a
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Jul
|
|
pubmed:issn |
0002-9270
|
|
pubmed:author |
pubmed-author:AngelettiClaudioC,
pubmed-author:AntonucciGiorgioG,
pubmed-author:BoumisEvangeloE,
pubmed-author:CapobianchiMaria RMR,
pubmed-author:ComandiniUbaldo ViscoUV,
pubmed-author:GirardiEnricoE,
pubmed-author:LongoMaria AntonellaMA,
pubmed-author:NotoPasqualeP,
pubmed-author:PRIDGENB FBF,
pubmed-author:SolmoneMaria CarmelaMC,
pubmed-author:TocciGuidoG,
pubmed-author:VairoFrancescoF
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
102
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1383-91
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:17403072-Adult,
pubmed-meshheading:17403072-Age Factors,
pubmed-meshheading:17403072-Aged,
pubmed-meshheading:17403072-Antiviral Agents,
pubmed-meshheading:17403072-Biopsy,
pubmed-meshheading:17403072-Drug Carriers,
pubmed-meshheading:17403072-Drug Therapy, Combination,
pubmed-meshheading:17403072-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:17403072-Female,
pubmed-meshheading:17403072-Follow-Up Studies,
pubmed-meshheading:17403072-Genotype,
pubmed-meshheading:17403072-Hepacivirus,
pubmed-meshheading:17403072-Hepatitis C, Chronic,
pubmed-meshheading:17403072-Hepatitis C Antibodies,
pubmed-meshheading:17403072-Humans,
pubmed-meshheading:17403072-Interferon-alpha,
pubmed-meshheading:17403072-Male,
pubmed-meshheading:17403072-Middle Aged,
pubmed-meshheading:17403072-Odds Ratio,
pubmed-meshheading:17403072-Polyethylene Glycols,
pubmed-meshheading:17403072-RNA, Viral,
pubmed-meshheading:17403072-Recombinant Proteins,
pubmed-meshheading:17403072-Retrospective Studies,
pubmed-meshheading:17403072-Reverse Transcriptase Polymerase Chain Reaction,
pubmed-meshheading:17403072-Ribavirin,
pubmed-meshheading:17403072-Time Factors,
pubmed-meshheading:17403072-Treatment Outcome
|
|
pubmed:year |
2007
|
|
pubmed:articleTitle |
The effect of age on response to therapy with peginterferon alpha plus ribavirin in a cohort of patients with chronic HCV hepatitis including subjects older than 65 yr.
|
|
pubmed:affiliation |
Clinical Department of Infectious Disease, National Institute for Infectious Disease, L. Spallanzani, Rome, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't,
Multicenter Study
|
